Fujifilm Kyowa Kirin Biologics selects GE’s innovative MabSelect SuRe LX media for biomanufacturing process

Share This.....Share on LinkedInTweet about this on TwitterShare on FacebookShare on Google+Email this to someone

Tokyo, Japan and Chalfont St Giles, UK – 7 September 2015 –  GE Healthcare today announced that Fujifilm Kyowa Kirin Biologics has selected GE Healthcare’s innovative MabSelect SuRe™ LX high-affinity chromatography media for the manufacture of monoclonal antibodies.